Insider Buy/Sell Ratio for August 2026
Ratio0.1:1
Daily Buy & Sell Volume
By Sector
Consumer Cyclical
Buys34
Sells446
Buy $$15.93M
Sell $$1.89B
Ratio1:118.53
% Change vs. Prior
Ratio +156.1%Value +37.3%
Technology
Buys74
Sells1678
Buy $$35.98M
Sell $$1.57B
Ratio1:43.65
% Change vs. Prior
Ratio -55.0%Value -32.1%
Financial Services
Buys159
Sells639
Buy $$23.49M
Sell $$1.12B
Ratio1:47.66
% Change vs. Prior
Ratio -96.0%Value -7.1%
Healthcare
Buys71
Sells806
Buy $$18.84M
Sell $$1.06B
Ratio1:56.40
% Change vs. Prior
Ratio -42.0%Value -35.3%
Consumer Defensive
Buys25
Sells89
Buy $$5.33M
Sell $$1.07B
Ratio1:201.42
% Change vs. Prior
Ratio -97.9%Value +471.7%
Energy
Buys38
Sells146
Buy $$20.55M
Sell $$895.05M
Ratio1:43.56
% Change vs. Prior
Ratio +61.6%Value +475.0%
Industrials
Buys51
Sells384
Buy $$118.55M
Sell $$452.16M
Ratio1:3.81
% Change vs. Prior
Ratio +915.1%Value -27.5%
Communication Services
Buys27
Sells156
Buy $$30.43M
Sell $$279.64M
Ratio1:9.19
% Change vs. Prior
Ratio +16861.5%Value +97.6%
Basic Materials
Buys28
Sells60
Buy $$2.73M
Sell $$48.45M
Ratio1:17.75
% Change vs. Prior
Ratio -94.0%Value +245.1%
Real Estate
Buys47
Sells37
Buy $$13.83M
Sell $$29.53M
Ratio1:2.14
% Change vs. Prior
Ratio +3592.5%Value +81.3%
Utilities
Buys7
Sells22
Buy $$1.46M
Sell $$5.61M
Ratio1:3.85
% Change vs. Prior
Ratio +32.4%Value -80.6%
By Industry
Beverages - Non-Alcoholic
Buys2
Sells5
Buy $$2.00M
Sell $$1.00B
Ratio1:500.50
Leisure
Buys3
Sells33
Buy $$746.99K
Sell $$668.18M
Ratio1:894.50
Asset Management
Buys24
Sells40
Buy $$11.23M
Sell $$576.21M
Ratio1:51.33
% Change vs. Prior
Ratio -97.3%Value +230.9%
Specialty Retail
Buys11
Sells156
Buy $$2.58M
Sell $$541.90M
Ratio1:210.31
% Change vs. Prior
Ratio +10.2%Value +159.4%
Oil & Gas Equipment & Services
Buys4
Sells41
Buy $$4.02M
Sell $$502.55M
Ratio1:125.06
Computer Hardware
Buys0
Sells306
Buy $$0.00
Sell $$477.07M
RatioAll Sells
% Change vs. Prior
Ratio NaN%Value -6.6%
Software - Infrastructure
Buys7
Sells562
Buy $$101.11K
Sell $$406.99M
Ratio1:4025.34
% Change vs. Prior
Ratio -73.4%Value -18.5%
Banks - Regional
Buys77
Sells302
Buy $$5.29M
Sell $$314.17M
Ratio1:59.44
Biotechnology
Buys30
Sells344
Buy $$3.23M
Sell $$305.02M
Ratio1:94.34
% Change vs. Prior
Ratio -67.8%Value -76.6%
Medical - Diagnostics & Research
Buys4
Sells244
Buy $$1.04M
Sell $$290.62M
Ratio1:280.17
Auto - Dealerships
Buys0
Sells19
Buy $$0.00
Sell $$289.51M
RatioAll Sells
Software - Application
Buys29
Sells417
Buy $$33.20M
Sell $$250.56M
Ratio1:7.55
% Change vs. Prior
Ratio -13.2%Value -58.5%
Internet Content & Information
Buys2
Sells85
Buy $$1.12M
Sell $$191.08M
Ratio1:170.25
Medical - Care Facilities
Buys2
Sells16
Buy $$202.20K
Sell $$180.68M
Ratio1:893.57
Oil & Gas Integrated
Buys0
Sells10
Buy $$0.00
Sell $$161.14M
RatioAll Sells
Transactions (5176)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
NETFLIX INC (NFLX)
Peters Gregory K — Director
Shares
27,312
Price
$73.54
Total Value
$2.01M
Shares Held After
120,931
% of Holdings
18.4%
Velocity Financial, Inc. (VEL)
Szczepaniak Mark R — Chief Financial Officer
Shares
400
Price
$18.00
Total Value
$7.20K
Shares Held After
66,400
% of Holdings
0.6%
Burke&Herbert Financial Services Corp. (BHRB)
McLaughlin Shawn Patrick — Director
Shares
1,000
Price
$73.25
Total Value
$73.25K
Shares Held After
71,000
% of Holdings
1.4%
Rhinebeck Bancorp, Inc. (RBKB)
Vitale Michael — EVP, Head of Comm Banking
Shares
4,834
Price
$12.35
Total Value
$59.70K
Shares Held After
22,414
% of Holdings
21.6%
WILSON BANK HOLDING CO (WBHC)
CLEMONS JAMES RANDALL — Director
Shares
2,982
Price
$83.45
Total Value
$248.85K
Shares Held After
116,090
% of Holdings
2.6%
FARMERS NATIONAL BANC CORP /OH/ (FMNB)
Wenick Mark J — SEVP/Chief Wealth Mgt Officer
Shares
5,000
Price
$15.97
Total Value
$79.85K
Shares Held After
32,020
% of Holdings
13.5%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
6,975
Price
$44.44
Total Value
$309.97K
Shares Held After
0
% of Holdings
100.0%
SILICOM LTD. (SILC)
Gilad Eran — CFO
Shares
25
Price
$46.56
Total Value
$1.16K
Shares Held After
6,975
% of Holdings
0.4%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
753
Price
$21.97
Total Value
$16.54K
Shares Held After
75,542
% of Holdings
1.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
100
Price
$22.11
Total Value
$2.21K
Shares Held After
76,295
% of Holdings
0.1%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
480
Price
$21.55
Total Value
$10.34K
Shares Held After
76,395
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.10
Total Value
$4.42K
Shares Held After
76,875
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
3,402
Price
$22.02
Total Value
$74.91K
Shares Held After
77,075
% of Holdings
4.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,556
Price
$22.06
Total Value
$34.33K
Shares Held After
80,477
% of Holdings
1.9%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
76,418
Price
$21.04
Total Value
$1.61M
Shares Held After
0
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
82,033
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,763
Price
$21.61
Total Value
$146.15K
Shares Held After
55,611
% of Holdings
10.8%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
100
Price
$21.99
Total Value
$2.20K
Shares Held After
62,374
% of Holdings
0.2%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
1,332
Price
$22.03
Total Value
$29.34K
Shares Held After
82,233
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,163
Price
$22.19
Total Value
$25.81K
Shares Held After
62,474
% of Holdings
1.8%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
447
Price
$21.87
Total Value
$9.78K
Shares Held After
83,565
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
700
Price
$22.07
Total Value
$15.45K
Shares Held After
63,637
% of Holdings
1.1%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
200
Price
$22.05
Total Value
$4.41K
Shares Held After
64,337
% of Holdings
0.3%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
988
Price
$22.03
Total Value
$21.77K
Shares Held After
84,012
% of Holdings
1.2%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
443
Price
$21.78
Total Value
$9.65K
Shares Held After
64,537
% of Holdings
0.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
300
Price
$20.84
Total Value
$6.25K
Shares Held After
64,980
% of Holdings
0.5%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,040
Price
$22.05
Total Value
$22.93K
Shares Held After
65,280
% of Holdings
1.6%
Attovia Therapeutics, Inc. (ATTO)
GOLDMAN SACHS GROUP INC — Former 10% Owner
Shares
85,000
Price
$21.00
Total Value
$1.78M
Shares Held After
85,000
% of Holdings
100.0%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
1,180
Price
$21.84
Total Value
$25.77K
Shares Held After
66,320
% of Holdings
1.7%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
400
Price
$22.02
Total Value
$8.81K
Shares Held After
67,500
% of Holdings
0.6%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
6,970
Price
$22.03
Total Value
$153.55K
Shares Held After
67,900
% of Holdings
9.3%
Attovia Therapeutics, Inc. (ATTO)
WALSH COLIN — Director
Shares
672
Price
$22.02
Total Value
$14.80K
Shares Held After
74,870
% of Holdings
0.9%
Showing 251–300 of 5176 transactions (page 6 of 104)